T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Match Group
MTCH
|
+$3.31B |
| 2 |
Nike
NKE
|
+$2.27B |
| 3 |
FedEx
FDX
|
+$2.24B |
| 4 |
Bank of America
BAC
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.64B |
Top Sells
| 1 |
IAC Inc
IAC
|
+$3.91B |
| 2 |
Fortive
FTV
|
+$2.68B |
| 3 |
Alibaba
BABA
|
+$1.51B |
| 4 |
Linde
LIN
|
+$1.51B |
| 5 |
Willis Towers Watson
WTW
|
+$1.16B |
Sector Composition
| 1 | Technology | 25.65% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.89% |
| 4 | Financials | 11.37% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTEV
451
Claritev Corporation
CTEV
$1.02B
| $230M | 0.03% |
+561,804
| New | +$230M |
|
452
Iovance Biotherapeutics
IOVA
$861M
| $228M | 0.03% |
6,929,214
-343,216
| -5% | -$11.3M |
|
453
Western Alliance Bancorporation
WAL
$9.93B
| $227M | 0.03% |
7,168,712
+175,995
| +3% | +$5.56M |
|
|
ONC
454
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.9B
| $225M | 0.03% |
786,418
+189,163
| +32% | +$54.2M |
|
|
DNB
455
DELISTED
Dun & Bradstreet
DNB
| $225M | 0.03% |
+8,778,354
| New | +$225M |
|
456
Sprouts Farmers Market
SFM
$13.4B
| $225M | 0.03% |
10,733,542
+1,037,965
| +11% | +$21.7M |
|
457
AES
AES
$9.17B
| $223M | 0.03% |
12,340,191
+8,808,354
| +249% | +$160M |
|
458
ESCO Technologies
ESE
$5.43B
| $222M | 0.03% |
2,758,293
-2,888
| -0.1% | -$233K |
|
|
CVET
459
DELISTED
Covetrus, Inc. Common Stock
CVET
| $222M | 0.03% |
9,085,592
-555,866
| -6% | -$13.6M |
|
460
Southwest Gas
SWX
$5.68B
| $221M | 0.03% |
3,494,621
-390,548
| -10% | -$24.6M |
|
461
Xencor
XNCR
$602M
| $220M | 0.03% |
5,684,073
+284,578
| +5% | +$11M |
|
462
Outset Medical
OM
$252M
| $220M | 0.03% |
+305,292
| New | +$220M |
|
463
Landstar System
LSTR
$4.58B
| $220M | 0.03% |
1,750,443
-35,412
| -2% | -$4.44M |
|
464
Regency Centers
REG
$13.1B
| $218M | 0.03% |
5,728,023
+339,975
| +6% | +$12.9M |
|
|
MRTX
465
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $218M | 0.03% |
1,311,262
+2,410
| +0.2% | +$400K |
|
466
Bankunited
BKU
$2.96B
| $217M | 0.03% |
9,884,977
+706,866
| +8% | +$15.5M |
|
|
JBTM
467
JBT Marel Corporation
JBTM
$7.29B
| $216M | 0.03% |
2,352,254
-203,479
| -8% | -$18.7M |
|
468
Martin Marietta Materials
MLM
$37.9B
| $216M | 0.03% |
916,323
+3,547
| +0.4% | +$835K |
|
469
Alexandria Real Estate Equities
ARE
$14.5B
| $215M | 0.02% |
1,343,748
-10,572
| -0.8% | -$1.69M |
|
|
BSX.PRA
470
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $214M | 0.02% |
1,914,919
-100
| -0% | -$11.2K |
|
471
Five Below
FIVE
$8.06B
| $213M | 0.02% |
1,678,108
+8,610
| +0.5% | +$1.09M |
|
472
Snap-on
SNA
$17.2B
| $213M | 0.02% |
1,447,466
+46,687
| +3% | +$6.87M |
|
|
CUB
473
DELISTED
Cubic Corporation
CUB
| $210M | 0.02% |
3,610,958
-28,566
| -0.8% | -$1.66M |
|
474
Penumbra
PEN
$10.8B
| $210M | 0.02% |
1,080,008
-34,424
| -3% | -$6.69M |
|
475
Banco Santander Chile
BSAC
$12.5B
| $207M | 0.02% |
14,901,221
-1,323,643
| -8% | -$18.3M |
|